Key scientists of Chiralabs include:
|
The Chiralabs scientific effort
is overseen and guided by George E. Tranter PhD
MA BSc |
|
The Science Director is Delphine D. Le Pevelen Dr DEA MSP
LSP DEUG, an expert in crystallography and the crystal growth of natural and synthetic compounds, particularly
pharmaceuticals and organometallics (inc. metallo-drugs). She is co-inventor of the internationally
award-winning rational crystallisation screening technology CrystalGEM and an authority on the properties
of solvent/anti-solvent systems. Dr Le Pevelen has held research positions in leading university laboratories
in the UK
|
|
|
FRSC CChem
CSci, who has held senior R&D positions in both industry and academia (including
at London University, Oxford University, the Wellcome Foundation and GlaxoWellcome). Until 2006 he led the
Biospectroscopy Centre of Imperial College London and subsequently was Senior Research Fellow of the Department of
Chemistry, University of Oxford. He is a recognised international authority in the field of molecular
chirality and the spectroscopic/physicochemical features of drugs and biopharmaceuticals. He is named
as inventor on drug patents, has published widely in the scientific literature,
co-edited
and validate biopharmaceutical
structure and function. His particular interests are in the rational discovery of new therapeutics, with a passion
for the role chirality plays in nature, from the molecular level through to macroscopic structures (e.g. helical
shells) and beyond. 
and France
and is a regular contributor to scientific meetings and symposia. Her particular interests are in solving complex
crystal structures and understanding crystal growth phenomena, including the rationalisation and control of polymorphism,
enantiomorphism, morphology, solvates, salts and co-crystal formation.